Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancer

Research objective: To study the role of prognostic factors in the estimation of risk development of recurrent prostate cancer after treatment by high-intensive focused ultrasound (HIUF). Objects and Research Methods: The research has included 102 patients with morphologically revealed localized pro...

Full description

Bibliographic Details
Main Authors: Popkov V.M., Fomkin R.N., Blyumberg B.I.
Format: Article
Language:Russian
Published: Saratov State Medical University 2013-03-01
Series:Саратовский научно-медицинский журнал
Subjects:
Online Access:http://www.ssmj.ru/system/files/2013-01_116-121.pdf
_version_ 1819150608492396544
author Popkov V.M.
Fomkin R.N.
Blyumberg B.I.
author_facet Popkov V.M.
Fomkin R.N.
Blyumberg B.I.
author_sort Popkov V.M.
collection DOAJ
description Research objective: To study the role of prognostic factors in the estimation of risk development of recurrent prostate cancer after treatment by high-intensive focused ultrasound (HIUF). Objects and Research Methods: The research has included 102 patients with morphologically revealed localized prostate cancer by biopsy. They have been on treatment in Clinic of Urology of the Saratov Clinical Hospital n.a. S. R. Mirotvortsev. 102 sessions of initial operative treatment of prostate cancer by the method of HIFU have been performed. The general group of patients (n=102) has been subdivided by the method of casual distribution into two samples: group of patients with absent recurrent tumor and group of patients with the revealed recurrent tumor, by morphological research of biopsy material of residual prostate tissue after HIFU. The computer program has been used to study the signs of outcome of patients with prostate cancer. Results: Risk of development of recurrent prostate cancer has grown with the PSA level raise and its density. The index of positive biopsy columns <0,2 has shown the recurrence of prostate cancer in 17% cases while occurrence of prostate cancer in 59% cases has been determined by the index of 0,5 and higher. The tendency to obvious growth of number of relapses has been revealed by the sum of Glison raise with present perineural invasion. Cases of recurrent prostate cancer have been predominant in patients with lymphovascular invasions. In conclusion it has been worked out that the main signs of recurrent prostate cancer development may include: PSA, PSA density, the sum of Glison, lymphovascular invasion, invasion.
first_indexed 2024-12-22T14:20:12Z
format Article
id doaj.art-b1f11c3f29054e438cadff3ec13a244a
institution Directory Open Access Journal
issn 1995-0039
2076-2518
language Russian
last_indexed 2024-12-22T14:20:12Z
publishDate 2013-03-01
publisher Saratov State Medical University
record_format Article
series Саратовский научно-медицинский журнал
spelling doaj.art-b1f11c3f29054e438cadff3ec13a244a2022-12-21T18:23:01ZrusSaratov State Medical UniversityСаратовский научно-медицинский журнал1995-00392076-25182013-03-0191116121Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancerPopkov V.M.Fomkin R.N.Blyumberg B.I.Research objective: To study the role of prognostic factors in the estimation of risk development of recurrent prostate cancer after treatment by high-intensive focused ultrasound (HIUF). Objects and Research Methods: The research has included 102 patients with morphologically revealed localized prostate cancer by biopsy. They have been on treatment in Clinic of Urology of the Saratov Clinical Hospital n.a. S. R. Mirotvortsev. 102 sessions of initial operative treatment of prostate cancer by the method of HIFU have been performed. The general group of patients (n=102) has been subdivided by the method of casual distribution into two samples: group of patients with absent recurrent tumor and group of patients with the revealed recurrent tumor, by morphological research of biopsy material of residual prostate tissue after HIFU. The computer program has been used to study the signs of outcome of patients with prostate cancer. Results: Risk of development of recurrent prostate cancer has grown with the PSA level raise and its density. The index of positive biopsy columns <0,2 has shown the recurrence of prostate cancer in 17% cases while occurrence of prostate cancer in 59% cases has been determined by the index of 0,5 and higher. The tendency to obvious growth of number of relapses has been revealed by the sum of Glison raise with present perineural invasion. Cases of recurrent prostate cancer have been predominant in patients with lymphovascular invasions. In conclusion it has been worked out that the main signs of recurrent prostate cancer development may include: PSA, PSA density, the sum of Glison, lymphovascular invasion, invasion.http://www.ssmj.ru/system/files/2013-01_116-121.pdfhigh intensity focused ultrasound (HIFU)prognostic factorsprostate cancerprostate-specific antigenultrasound surgery
spellingShingle Popkov V.M.
Fomkin R.N.
Blyumberg B.I.
Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancer
Саратовский научно-медицинский журнал
high intensity focused ultrasound (HIFU)
prognostic factors
prostate cancer
prostate-specific antigen
ultrasound surgery
title Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancer
title_full Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancer
title_fullStr Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancer
title_full_unstemmed Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancer
title_short Prognostic factors in the estimation of HIFU treatment efficiency in patients with localized prostate cancer
title_sort prognostic factors in the estimation of hifu treatment efficiency in patients with localized prostate cancer
topic high intensity focused ultrasound (HIFU)
prognostic factors
prostate cancer
prostate-specific antigen
ultrasound surgery
url http://www.ssmj.ru/system/files/2013-01_116-121.pdf
work_keys_str_mv AT popkovvm prognosticfactorsintheestimationofhifutreatmentefficiencyinpatientswithlocalizedprostatecancer
AT fomkinrn prognosticfactorsintheestimationofhifutreatmentefficiencyinpatientswithlocalizedprostatecancer
AT blyumbergbi prognosticfactorsintheestimationofhifutreatmentefficiencyinpatientswithlocalizedprostatecancer